JMJD2A Antibody

JMJD2A Antibodyis available at Gentaur for Next week Delivery.

Description: Jumonji Domain containing 2A (JMJD2A) is a lysine specific demethylase with emerging roles in histone modification or epigenetic remodeling. This JMJD2A polyclonal antibody was raised against an N-terminal recombinant fragment of JMJD2A. This fragment includes amino acids 1-350 including the JMJN and JMJC domains but not the two LAP/PHD zinc finger or Tudor domains of the 1,064 amino acid protein. JMJD2A is detected at 135 kDa by western blotting using a DLD1 cell lysate as a positive control. Also, the expression of JMJD2A varies by tissue, and northern blotting sμggests skeletal muscle as a negative control and lung as a positive control tissue.

Immunogen Sequence:Human recombinant JMJD2A aa 1-350

Target Alternative Name:Jumonji Domain Containing 2A; KDM4A; Lysine-Specific Demethylase 4A

Species Reactivities:Human JMJD2A. Expected to cross react with JMJD2C (>90% similarity), JMJD2B (>85% similarity) due to high homology to these JMJD2 paralogs considering the antigen used. Observed detection of purified recombinant human JMJD2D at 50 ng sμggesting only ~10% cross reactivity with recombinant JMJD2D, however bands were detected at 60 kDa from cell samples.

Tag Line:Polyclonal antibody to detect JMJD2A (a lysine specific demethylase ) in human samples

Formulation:100 µl of antibody in TBS, pH 7.4, containing 50% glycerol, 0.5 mg/ml BSA, and 0.02% sodium azide.

Purification: Antigen affinity purified

Application:Western blot

Positive Control:Western blot: DLD1 cell lysate

Application And Usages:Western blot: 1:200 dilution. Not recommended for FACS and IHC based on probable cross reactivity with other JMJD containing proteins.

Handling:The antibody solution should be gently mixed before use.